Immediate Impact

38 from Science/Nature 101 standout
Sub-graph 1 of 23

Citing Papers

Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance
2024 Standout
Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis
2021 Standout

Works of John A. Dougherty being referenced

Antibiotic Approvals in the Last Decade: Are We Keeping Up With Resistance?
2021
A Systematic Review of Newer Antidiabetic Agents in the Treatment of Nonalcoholic Fatty Liver Disease
2020

Author Peers

Author Last Decade Papers Cites
John A. Dougherty 140 241 23 241 32 868
Jerome H. Chin 276 158 10 240 42 946
Jag Khalsa 153 313 2 167 62 1.0k
Wayne X. Shandera 150 188 9 286 32 1.1k
Charles Brummitt 191 256 2 214 28 908
Nicholas Hartman 115 106 3 127 55 918
Md. Abdullah Saeed Khan 139 110 18 287 95 1.2k
D. Henzel 69 220 12 222 58 1.1k
Cheryl A. Jay 138 155 203 16 1.0k
Kevin Gough 84 376 1 495 43 1.0k
Norma Muurahainen 75 87 8 187 19 777

All Works

Loading papers...

Rankless by CCL
2026